Quantamental Technologies LLC Gilead Sciences, Inc. Transaction History

Quantamental Technologies LLC

$105 Million
Q3 2023

A detailed history of Quantamental Technologies LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Quantamental Technologies LLC holds 4,310 shares of GILD stock, worth $534,827. This represents 0.31% of its overall portfolio holdings.

Number of Shares

4,310

Previous 3,343 28.93%

Holding current value

$534,827

Previous $257,000 25.29%

% of portfolio

0.31%

Previous 0.11%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $71,499 - $78,007	967 Added 28.93%	4,310 $322,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $19,838 - $22,628	-261 Reduced 7.24%	3,343 $257,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $278,625 - $317,440	3,604 New	3,604 $299,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $287,157 - $323,424	4,975 New	4,975 $308,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $237,695 - $259,715	-3,745 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $224,700 - $256,382	3,745 New	3,745 $242,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.91 Million - $2.18 Million	-33,770 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $835,058 - $1.05 Million	13,447 Added 66.17%	33,770 $2.13 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $597,166 - $693,420	8,255 Added 68.4%	20,323 $1.56 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $391,124 - $500,973	6,245 Added 107.25%	12,068 $902,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $473,056 - $520,347	-7,677 Reduced 56.87%	5,823 $378,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $69,823 - $77,073	-1,117 Reduced 7.64%	13,500 $856,000
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $233,682 - $262,048	3,777 Added 34.84%	14,617 $988,000
Q1 2019 Apr 29, 2019	BUY	$62.53 - $70.05 $453,655 - $508,212	7,255 Added 202.37%	10,840 $705,000
Q4 2018 Jan 28, 2019	BUY	$60.54 - $79.0 $217,035 - $283,215	3,585 New	3,585 $224,000

Others Institutions Holding GILD

# of Institutions

2,369

Shares Held

1.01B

Call Options Held

8.58M

Put Options Held

7.35M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.

Account

Quantamental Technologies LLC Gilead Sciences, Inc. Transaction History